An interventional study of Rotational atherectomy and Cutting Balloon Angioplasty in Coronary Artery Disease, sponsored by Icahn School of Medicine at Mount Sinai. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-05-14.
Sponsored by Icahn School of Medicine at Mount Sinai · Not applicable, Interventional, and Treatment
The purpose of this study is to predict any changes in the side branch after stenting the main branch blood vessel using three dimensional intravascular images. (Frequency domain optical coherence tomography FD OCT).
Optical coherence tomography (OCT) is an established medical imaging technique that uses light to capture high-resolution, three-dimensional images of blood vessels. These images will be used before and after implanting the stent in the main blood vessel. Fractional Flow Reserve (FFR) test, which makes it possible for the interventional cardiologist to calculate blood flow across an area of a coronary artery, will be done after stenting and will help to determine if there are any changes in the side branch blood flow.
Coronary artery bifurcation lesion is a common lesion subset in PCI accounting for 15-20% of the total number of interventions. Treatment of coronary artery bifurcation lesions represents a challenging area in interventional cardiology. When compared with non-bifurcation interventions, bifurcation interventions have a lower rate of procedural success, higher procedural costs, longer hospitalization and a higher clinical and angiographic restenosis. Factors contributing to this adverse outcome include limitations of angiography in assessment of side-branch (SB) disease severity and the lack of established angiographic predictors of SB patency and lumen compromise. Better understanding of the underlying plaque morphology and plaque composition may facilitate more effective treatment of bifurcation lesions.
Intravascular imaging has provided new understanding of mechanisms associated with SB compromise following bifurcation PCI. Plaque shift has been traditionally considered as the principal mechanism for side-branch compromise after main vessel intervention. Rotational atherectomy(RA) has been advocated for the treatment of bifurcation lesions, since it can effectively remove plaque with minimal injury to adjacent normal arterial segments and potentially reduce plaque shifting, the "snow plow" effect. Intravascular ultrasound (IVUS) has been used for guidance in bifurcation lesions, aiding the visualization of plaque morphology at the main vessel and the side-branches and helping the selection of stent size and length as well as the selection of stenting strategy. However, due to the low spatial resolution of IVUS, all attempts for three-dimensional visualization have only focused on visualization of the luminal contour and not on the vessel morphology or the vessel-stent interaction. Optical coherence tomography (OCT) has \~10 times higher resolution than IVUS, which allows precise evaluation of the microstructure of the vessel wall including lipid pool, fibrous cap, calcification, and thrombus. OCT has been shown to constitute a valuable tool for PCI guidance and also the utility of three-dimensional (3D) renderings for assessing the mechanism of side-branch compromise following intervention in bifurcation lesions. The recent development of OCT with online 3D reconstruction allows the operator to obtain a 3D visualization of the lesion and may provide a unique tool for guidance during complex bifurcation PCI and potentially improve stenting results. 3D OCT has been used to visualize jailed side branches after implantation of bioresorbable scaffolds in the main branch and develop a new classification system based on the number of SB compartments. In addition, its potential clinical application in guiding the rewiring of the distal compartment of the SB ostium (jailed with stent struts after MB stenting) to minimize the risk of floating struts was demonstrated It is important to note that while OCT, 3D-OCT, and 3D-QCA (such as that used in the ORBID trial) are imaging modalities that can be used to answer important research questions, their wide-spread adoption in daily clinical practice has been very limited. Intravascular ultrasound (IVUS) is used more frequently as part of a PCI guidance strategy in daily clinical practice.
Fractional flow reserve (FFR) is a pressure-derived, lesion specific index used to determine the functional significance of coronary artery stenosis. Several studies showed that FFR is a safe and feasible method to assess the significance of an ostial SB stenosis after provisional stenting. Quantitative coronary angiography (QCA) has been shown to be unreliable in assessing the functional significance of SB after stent implantation in MV (the area under the curve 0.64, 41.5% sensitivity and 83.1% specificity) suggesting that treatment decisions for jailed SB should not be based on angiographic findings alone. A recent report demonstrated a better ability of post-PCI 3D-OCT to predict the functional significance for SB ostial lesions caused by a jailed SB outcome.
A previous study (ORBID) of 30 patients was done at Mount Sinai Hospital and aimed to identify the predictors of side branch (SB) ostial stenosis developed after provisional stenting of the main vessel (MV) using Optical Coherence Tomography (OCT). The study Showed that High lipid content of the MV lesion and a contralateral location of lipid in the bifurcation area may contribute to SBOS after provisional stenting.
The objective of this study is to analyze the incidence of SB compromise after provisional main vessel stenting in calcified bifurcation lesions of CAD patients, determine the incidence and OCT predictors of functionally significant SB stenosis defined as FFR ≤ 0.8 and to compare the FFR values with 3D-OCT measurements of jailed SB ostium after MV stenting.
Stable CAD patients with bifurcation lesions in whom provisional stenting strategy is planned, who have moderate or severe calcification in the main vessel lesion identified by angiography, SB stenosis 30-70% and SB reference diameter > 2mm will be enrolled in the study.
Moderate calcification will be defined as radiopaque density observed only during the cardiac cycle and typically involving only one side of the vascular wall, and severe calcification will be defined as radiopaque density noted without cardiac motion prior to contrast injection and involving both sides of the arterial wall. After completion of diagnostic angiogram and confirmation of subject eligibility, subjects will be randomly assigned to Rotational Atherectomy (RA) or Cutting Balloon Angioplasty (CBA)/Percutaneous Transluminal Coronary Angioplasty (PTCA) group in a 1:1 fashion.
Patients in both groups will undergo PCI with stent implantation according to current standards of care. Lesion preparation including lesion pre-dilation, scoring or sculpting balloon angioplasty, and use of atherectomy and protection devices will be performed at the operator's discretion, followed by MV stenting. The operator will also decide in both groups about the length and size of the implanted stent. Procedural optimization, such as post-dilation or additional stent implantation will be performed based only on the angiographic findings, according to the discretion of the operator.
5,598 studies on the registry are indexed under Coronary Artery Disease; 955 are open to participants now.
This study's enrollment of 71 is below the median of 123 across 3,435 interventional studies indexed under Coronary Artery Disease.
Browse Coronary Artery Disease studies →Icahn School of Medicine at Mount Sinai is the lead sponsor of 764 studies on the registry; 181 are open to participants now.
Of its 121 completed or terminated interventional studies of FDA-regulated products, 82 (68%) have results posted.
Counted across the registry records on this site, refreshed daily.
The target vessel must be a native coronary artery with
Exclusion Criteria:
Rotational atherectomy (RA)
Device: Rotational atherectomy
Cutting Balloon Angioplasty (CBA) or Percutaneous transluminal coronary angioplasty (PTCA)
Device: Cutting Balloon Angioplasty
Rotational atherectomy for the treatment of bifurcation lesions to remove plaque with minimal injury to adjacent normal arterial segments and potentially reduce plaque shifting, the "snow plow" effect.
Also known as: RA
Cutting balloon is a special balloon catheter with three or four microsurgical blades attached longitudinally to its surface, suitable for creating discrete longitudinal incisions in the atherosclerotic target coronary segment during balloon inflation. Lesion preparation will be performed using Cutting Balloon or conventional balloon
Also known as: CBA
Number of Participants With Side Branch Compromise
Number of participants with Side Branch (SB) compromise which is defined as SB DS \> 70%, or dissection or TIMI \< 3
Time frame: Day 1
Number of Participants With SB Dissection
Number of participants with SB dissection
Time frame: Day 1
Number of Participants With TIMI < 3
Number of participants with TIMI flow grade \< 3
Time frame: Day 1
Number of Participants With SB DS >70%
Number of participants with Side Branch Diameter Stenosis (DS) \> 70%
Time frame: Day 1
Number of Participants With FFR Device Success
Number of Participants with successfully deliver Fractional Flow Reserve (FFR) wire to desired SB distal segment
Time frame: Day 1
Number of Patients With FFR Wire Workhorse Capability
FFR Wire Workhorse Capability - Number of patients in which FFR wire was able to serve as rail to deliver additional interventional devices to target SB lesion
Time frame: Day 1
Participants enrolled between May 2017 and March 2019.
| Milestone | Rotational Atherectomy | CBA/PTCA |
|---|---|---|
| Started | 35 | 36 |
| Completed | 35 | 36 |
| Not completed | 0 | 0 |
Number of participants with Side Branch (SB) compromise which is defined as SB DS \> 70%, or dissection or TIMI \< 3
| Participants | Rotational Atherectomy | CBA/PTCA |
|---|---|---|
| Number of Participants With Side Branch Compromise | 7 | 9 |
Number of participants with SB dissection
| Participants | Rotational Atherectomy | CBA/PTCA |
|---|---|---|
| Number of Participants With SB Dissection | 1 | 0 |
Number of participants with TIMI flow grade \< 3
| Participants | Rotational Atherectomy | CBA/PTCA |
|---|---|---|
| Number of Participants With TIMI < 3 | 3 | 5 |
Number of participants with Side Branch Diameter Stenosis (DS) \> 70%
| Participants | Rotational Atherectomy | CBA/PTCA |
|---|---|---|
| Number of Participants With SB DS >70% | 2 | 4 |
Number of Participants with successfully deliver Fractional Flow Reserve (FFR) wire to desired SB distal segment
| Participants | Rotational Atherectomy | CBA/PTCA |
|---|---|---|
| Number of Participants With FFR Device Success | 28 | 27 |
FFR Wire Workhorse Capability - Number of patients in which FFR wire was able to serve as rail to deliver additional interventional devices to target SB lesion
| Participants | Rotational Atherectomy | CBA/PTCA |
|---|---|---|
| Number of Patients With FFR Wire Workhorse Capability | 0 | 0 |
Collected over 1 Day. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Rotational Atherectomy | 0/35 (0%) | 0/35 (0%) | 3/35 (8.6%) |
| CBA/PTCA | 0/36 (0%) | 0/36 (0%) | 1/36 (2.8%) |
| Event | Rotational Atherectomy | CBA/PTCA |
|---|---|---|
| LM dissection with contrast injectingSurgical and medical procedures | 1/35 | 0/36 |
| Right CFA access side bleedingSurgical and medical procedures | 1/35 | 0/36 |
| Dissection MinorCardiac disorders | 1/35 | 0/36 |
| Side branch closureCardiac disorders | 1/35 | 0/36 |
| Staged PCI pf p:CS-OM1Cardiac disorders | 1/35 | 0/36 |
| Chest PainCardiac disorders | 0/35 | 1/36 |
| Transient sidebranch closingCardiac disorders | 0/35 | 1/36 |
| Age, Continuous(years) | Rotational Atherectomy | CBA/PTCA | Total |
|---|---|---|---|
| Mean | 67.8 ± 10.5 | 66.6 ± 9.9 | 67.2 ± 10.1 |
| Sex: Female, Male(Participants) | Rotational Atherectomy | CBA/PTCA | Total |
|---|---|---|---|
| Female | 7 | 14 | 21 |
| Male | 28 | 22 | 50 |
| Race and Ethnicity Not Collected(Participants) | Rotational Atherectomy | CBA/PTCA | Total |
|---|---|---|---|
| Count of participants | — | — | 0 |
| Diabetes Mellitus(Participants) | Rotational Atherectomy | CBA/PTCA | Total |
|---|---|---|---|
| Count of participants | 11 | 14 | 25 |
| Hypertension(Participants) | Rotational Atherectomy | CBA/PTCA | Total |
|---|---|---|---|
| Count of participants | 28 | 30 | 58 |
| Hyperlipidemia(Participants) | Rotational Atherectomy | CBA/PTCA | Total |
|---|---|---|---|
| Count of participants | 32 | 29 | 61 |
| Current smoker(Participants) | Rotational Atherectomy | CBA/PTCA | Total |
|---|---|---|---|
| Count of participants | 5 | 1 | 6 |
| Previous myocardial infarction(Participants) | Rotational Atherectomy | CBA/PTCA | Total |
|---|---|---|---|
| Count of participants | 7 | 3 | 10 |
7 further baseline measures are reported on the registry.
Documents are hosted by the registry — open the source record to download them.
Plan to share: No
This study is completed, as verified in May 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Icahn School of Medicine at Mount Sinai